Proto-Oncogene Proteins c-bcl-6
"Proto-Oncogene Proteins c-bcl-6" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A DNA-binding protein that contains an N-terminal BTB (POZ) DOMAIN and C-terminal CYS2-HIS2 ZINC FINGERS. It represses GENETIC TRANSCRIPTION of target genes by recruiting HISTONE DEACETYLASES. Aberrant Blc-6 expression is associated with certain types of human B-CELL LYMPHOMA.
| Descriptor ID |
D051560
|
| MeSH Number(s) |
D12.776.260.660 D12.776.624.664.700.170 D12.776.930.715
|
| Concept/Terms |
Proto-Oncogene Proteins c-bcl-6- Proto-Oncogene Proteins c-bcl-6
- Proto Oncogene Proteins c bcl 6
- c-bcl-6, Proto-Oncogene Proteins
- B-Cell Lymphoma 6 Protein
- B Cell Lymphoma 6 Protein
- Zinc Finger Protein 51
- c-bcl-6 Protein
- c bcl 6 Protein
- bcl-6 Proto-Oncogene Proteins
- Proto-Oncogene Proteins, bcl-6
- bcl 6 Proto Oncogene Proteins
- c-bcl-6 Proto-Oncogene Proteins
- Proto-Oncogene Proteins, c-bcl-6
- c bcl 6 Proto Oncogene Proteins
- Proto-Oncogene Protein bcl-6
- Proto Oncogene Protein bcl 6
- bcl-6, Proto-Oncogene Protein
- Proto-Oncogene Protein c-bcl-6
- Proto Oncogene Protein c bcl 6
|
Below are MeSH descriptors whose meaning is more general than "Proto-Oncogene Proteins c-bcl-6".
Below are MeSH descriptors whose meaning is more specific than "Proto-Oncogene Proteins c-bcl-6".
This graph shows the total number of publications written about "Proto-Oncogene Proteins c-bcl-6" by people in this website by year, and whether "Proto-Oncogene Proteins c-bcl-6" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 2 | 2 |
| 2002 | 0 | 2 | 2 |
| 2003 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2007 | 1 | 1 | 2 |
| 2010 | 1 | 1 | 2 |
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 3 | 4 |
| 2013 | 0 | 2 | 2 |
| 2014 | 1 | 2 | 3 |
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 1 | 2 |
| 2020 | 1 | 0 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Proto-Oncogene Proteins c-bcl-6" by people in Profiles.
-
Transcriptional programming of translation by BCL6 controls skeletal muscle proteostasis. Nat Metab. 2024 Feb; 6(2):304-322.
-
The transcription factor BCL-6 controls early development of innate-like T cells. Nat Immunol. 2020 09; 21(9):1058-1069.
-
Dynamic regulation of T follicular regulatory cell responses by interleukin 2 during influenza infection. Nat Immunol. 2017 Nov; 18(11):1249-1260.
-
Expression Pattern of the BCL6 and ITM2B Proteins in Normal Human Brains and in Alzheimer Disease. Appl Immunohistochem Mol Morphol. 2017 08; 25(7):489-496.
-
Gut Microbiota Regulates K/BxN Autoimmune Arthritis through Follicular Helper T but Not Th17 Cells. J Immunol. 2016 Feb 15; 196(4):1550-7.
-
Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma. Cancer. 2016 Feb 15; 122(4):559-64.
-
The ITM2B (BRI2) gene is a target of BCL6 repression: Implications for lymphomas and neurodegenerative diseases. Biochim Biophys Acta. 2015 May; 1852(5):742-8.
-
A BCL6/BCOR/SIRT1 complex triggers neurogenesis and suppresses medulloblastoma by repressing Sonic Hedgehog signaling. Cancer Cell. 2014 Dec 08; 26(6):797-812.
-
Bcl-6 directly represses the gene program of the glycolysis pathway. Nat Immunol. 2014 Oct; 15(10):957-64.
-
MYC-associated and double-hit lymphomas: a review of pathobiology, prognosis, and therapeutic approaches. Cancer. 2014 Dec 15; 120(24):3884-95.